Abstract
Current challenges with ocular drug delivery and the chronic nature of many ocular ailments render the use of traditional ocular devices for additional drug delivery purposes very attractive. To achieve this feat, there is the need to develop biomaterials that are biocompatible, mechanically robust for ocular applications, highly transparent (depending on the targeted ocular device), and with ultralow protein adhesion potential (the primary step in processes that lead to fouling and potential device failure). Herein is reported the facile synthesis of a novel, highly transparent, mechanically robust, nontoxic, bulk functionalized hydrogel with characteristics suited to scalable fabrication of ocular implantable and nonimplantable devices. Synergistic superhydrophilicity between methacrylated poly(vinyl alcohol) (PVAGMA) and zwitterionic sulfobetaine methacrylate was exploited to obtain a superhydrophilic polymer conjugate through facile photoinitiated cross-linking polymerization. Proton nuclear magnetic resonance (1H NMR), attenuated total reflectance-Fourier transform infrared spectroscopy (ATF-FTIR), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC) were used to confirm the synthesis and establish the physicochemical parameters for both the starting materials, the conjugated polymer, and the hydrogels. Cytotoxicity and cell adhesion potential evaluated in primary human retinal epithelial cells showed no toxicity or adhesion of the ocular cells. Biofilm adhesion studies in Escherichia coli and Staphylococcus aureus showed over 85% reduction in biofilm adhesion for the best-modified polymer compared to the unconjugated PVAGMA, highlighting its antifouling potential.